Analyst Ratings for ARIAD Pharmaceuticals (ARIA) [Neutrals]
ARIA Rating Summary
ARIA Price Target Summary
- Highest: $36.00 (RBC Capital)
- Lowest: $15.00 (Rodman & Renshaw)
- Average: $25.06
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$25.06 (+28%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/28/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
20.00 (N/A) |
18.31 | 19.57 | 6.88% | Details |
| 10/23/2012 | Oppenheimer » Updated 1/3/2013 |
Downgrade | Perform (Outperform) |
23.00 (23.00) |
22.79 | 19.57 | -14.13% | Details |
| 12/9/2011 | Barclays » Updated 10/22/2012 |
New Coverage | Equalweight (N/A) |
30.00 (25.00) |
11.15 | 19.57 | 75.52% | Details |
